CHD1L and cancer: On the other hand, analysis of NKT cell infiltration, a cell that has a strong anti-tumor action and was selected as a target for cancer immunotherapy development (Liu et al., 2021) demonstrated that half of the analyzed tumors experienced a negative correlation between CHD1L expression and NKT cells infiltration (Figure 7B), and again there was no tumor from the analyzed panel witnessed a positive correlation between CHD1L expression and NKT infiltration.